{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:59:42Z","timestamp":1773025182842,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ymgmr.2025.101191","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:23:56Z","timestamp":1737368636000},"page":"101191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Iskren","family":"Menkovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Makhijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areeg","family":"El-Gharbawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlee R.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ymgmr.2025.101191_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101144","article-title":"GM1 gangliosidosis type II: results of a 10-year prospective study","volume":"26","author":"D\u2019Souza","year":"2024","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2025.101191_bb0010","first-page":"602","article-title":"GM1 gangliosidosis: patients with different phenotypic features and novel mutations","volume":"36","author":"Emecen Sanli","year":"2023","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 gangliosidosis: mechanisms and management","volume":"14","author":"Rha","year":"2021","journal-title":"Appl. Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101191_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028435","article-title":"Late-infantile GM1 gangliosidosis: A case report","volume":"101","author":"Noh","year":"2022","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101191_bb0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of type 1 infantile GM1 gangliosidosis: a literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpeds.2019.08.016","article-title":"The clinical and molecular spectrum of GM1 gangliosidosis","volume":"215","author":"Arash-Kaps","year":"2019","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101191_bb0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ajmg.a.63038","article-title":"GM1-gangliosidosis: the caregivers\u2019 assessments of symptom impact and most important symptoms to treat","volume":"191","author":"Bingaman","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101191_bb0040","first-page":"90","article-title":"Are GMI gangliosidosis and Morquio type B two different disorders or part of one phenotypic spectrum?","volume":"59","author":"Kingma","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0045","first-page":"11","article-title":"Measurement of elevated concentrations of urine Keratan sulfate by UPLC-MSMS in lysosomal storage disorders (LSDs): comparison of urine Keratan sulfate levels in MPS IVA versus other LSDs","volume":"34","author":"Ellsworth","year":"2017","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgmr.2025.101191_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.701","article-title":"Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"3","author":"Zhang","year":"2023","journal-title":"Curr. Protoc."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101191_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0060","unstructured":"LC-MS\/MS Assay for Quantitation of Disaccharides, LacNAc(S1) and LacNAc(S2), Derived from Keratan Sulfate in Human Urine. In. Novato, CA: Biomarin Pharmaceuticals, Inc."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101191_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cld.2012.03.012","article-title":"Approach to a patient with elevated serum alkaline phosphatase","volume":"16","author":"Siddique","year":"2012","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2025.101191_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3476(05)80630-4","article-title":"Hyperphosphatasemia in GM1 gangliosidosis","volume":"120","author":"Denis","year":"1992","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101191_bb0075","first-page":"85","article-title":"Transient hyperphosphatasemia in children","volume":"14","author":"Bassrawi","year":"2014","journal-title":"Sudan J. Paediatr."},{"issue":"7","key":"10.1016\/j.ymgmr.2025.101191_bb0080","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/s00431-023-04995-1","article-title":"Benign transient hyperphosphatasemia in infants and children: a retrospective database study","volume":"182","author":"Shkalim Zemer","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0085","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Mucopolysaccharidosis Type IVA","author":"Regier","year":"2013"},{"issue":"5","key":"10.1016\/j.ymgmr.2025.101191_bb0090","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3476(05)83338-4","article-title":"Hyperphosphatasemia in infantile GM1 gangliosidosis: possible association with microscopic bone marrow osteoblastosis","volume":"117","author":"Mogilner","year":"1990","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.ymgmr.2025.101191_bb0095","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ymgmr.2025.101191_bb0100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model","volume":"25","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101191_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/humu.9475","article-title":"GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling","volume":"28","author":"Caciotti","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 gangliosidosis-a mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgmr.2025.101191_bb0115","article-title":"Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling","volume":"20","author":"Ou","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"2","key":"10.1016\/j.ymgmr.2025.101191_bb0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2008.02.005","article-title":"Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis","volume":"94","author":"Elliot-Smith","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgmr.2025.101191_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1371","article-title":"Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: a multicenter experience","volume":"8","author":"Fischetto","year":"2020","journal-title":"Mol. Genet. Genomic Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T03:20:01Z","timestamp":1740712801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"alternative-id":["S2214426925000060"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101191","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101191"}}